Adaptive Capital Partners
VC Fund
Singapore, Singapore
Adaptive Capital Partners is a Singapore-based, earlystage technology-focused venture capital firm established in 2022. We invest in high-conviction and disruptive technology startups with a predominant focus on (i) Healthtech / Medtech and (ii) SEA B2B tech-enabled companies while working with founders in many of their defining challenges with our team’s deep experience as an operator and research background. We believe that venture capital is not just about numbers. It is about how well you understand the startups and create value for them. We are here as enablers to support entrepreneurs in their exceptional journey.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Adaptive Capital Partners invests in
Stages Adaptive Capital Partners invests in
Countries Adaptive Capital Partners invests in
Round sizes
Round size
- Series A
- $3.5M–$17M
Investment Focus
Industry
- Health Care 4 (50%)
- Fitness 1 (13%)
- Medical 1 (13%)
- mHealth 1 (13%)
- Internet 1 (13%)
Stage
- Series A 4 (50%)
- Funding Round 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- Singapore 3 (38%)
- Malaysia 1 (13%)
- United States 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| They offer platforms that are able to report clinical deterioration and provide recommended interventions with post-monitoring.They work in the health care industry, just like you. We take the time to get to know you, and we always keep your best interests in mind when adding and adjusting products in our catalog. | Series A / Sep 21, 2026 | ||
| They offer platforms that are able to report clinical deterioration and provide recommended interventions with post-monitoring.They work in the health care industry, just like you. We take the time to get to know you, and we always keep your best interests in mind when adding and adjusting products in our catalog. | $11.6M / Series A / Jul 23, 2025 | ||
| Lapasar.com is a B2B marketplace, giving corporate buyers access to suppliers across Malaysia - via the marketplace & via RFQ tools. To adhere to and strengthen corporate governance, the marketplace comes with integrated procurement tools in the backend. | $6.5M / Venture - Series Unknown / Feb 16, 2024 | ||
| Biorithm is a company that creates obstetrics remote monitoring platforms and point-of-care devices for pregnant and postnatal patients. The company combines proprietary data analytics software and medical-grade wearables to monitor a wide range of pregnancy vital data such as fetal heart rate, uterine contractions, and maternal heart rate,allowing clinicians to gain new insights into the health of the mother and baby while also providing expecting mothers with better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications. | $3.5M / Series A / Dec 18, 2023 | ||
| AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M / Series A / Oct 11, 2023 | ||
| Founded in 2017 by medical doctors and data scientists, Aktivolabs is on a mission to prevent chronic diseases globally. Our real-time digital health platform empowers enterprises & governments to build scalable, evidence-based health & well-being solutions. Clients include the world's largest Insurance companies, health super-apps,large employers, consumer products companies, and enterprise-level corporations. Aktivolabs investors include Mitsui & Co., SEEDS Capital (the investment arm of Enterprise Singapore), and Adaptive Capital Partners. The company is headquartered in Singapore with offices in New York, Cambridge UK, and India. To learn more, please visit the website www.aktivolabs.com. | $10M / Series A / Dec 14, 2022 | ||
| See all 8 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Adaptive Capital Partners invest in?
Adaptive Capital Partners invests primarily in Health Care, Fitness and Medical startups, most often at Series A and Funding Round stage. Most of the 8 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Adaptive Capital Partners invest in?
Adaptive Capital Partners typically joins rounds of $3.5M–$17M at Series A. These are whole funding-round sizes, not Adaptive Capital Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Adaptive Capital Partners took part in.
When did Adaptive Capital Partners last invest?
The most recent investment recorded for Adaptive Capital Partners closed in Sep 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
